These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36431169)

  • 1. Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes.
    Zhou Y; Huang H; Yan X; Hapca S; Bell S; Qu F; Liu L; Chen X; Zhang S; Shi Q; Zeng X; Wang M; Li N; Du H; Meng W; Su B; Tian H; Li S; On Behalf Of The WECODe Study Group
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Visit-to-Visit Variability in Hemoglobin A
    Xu Y; Dong S; Fu EL; Sjölander A; Grams ME; Selvin E; Carrero JJ
    Am J Kidney Dis; 2023 Sep; 82(3):267-278. PubMed ID: 37182597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study.
    Cheung JTK; Yang A; Wu H; Lau ESH; Shi M; Kong APS; Ma RCW; Luk AOY; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2023 Jan; 195():110203. PubMed ID: 36493912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial.
    van der Hoek S; Jongs N; Oshima M; Neuen BL; Stevens J; Perkovic V; Levin A; Mahaffey KW; Pollock C; Greene T; Wheeler DC; Jardine MJ; Heerspink HJL
    Clin J Am Soc Nephrol; 2023 Jun; 18(6):748-758. PubMed ID: 36999981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Long-Term HbA1c Variability and Functional Limitation in Individuals Aged Over 50 Years: A Retrospective Cohort Study.
    Shao D; Wang SS; Sun JW; Wang HP; Sun Q
    Front Endocrinol (Lausanne); 2022; 13():847348. PubMed ID: 35574024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes.
    Lee CL; Chen CH; Wu MJ; Tsai SF
    Ther Adv Chronic Dis; 2020; 11():2040622319898370. PubMed ID: 32166009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis.
    Kim H; Jung DY; Lee SH; Cho JH; Yim HW; Kim HS
    J Korean Med Sci; 2023 Jan; 38(4):e24. PubMed ID: 36718561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang KKL; Tang WE; Kwan PY; Tavintharan S; Sum CF; Lim SC
    Diab Vasc Dis Res; 2018 Sep; 15(5):417-423. PubMed ID: 29807475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Negri C; Stoico V; Bonora E
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):401-8. PubMed ID: 22282481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes.
    Takenouchi A; Tsuboi A; Terazawa-Watanabe M; Kurata M; Fukuo K; Kazumi T
    J Diabetes Metab Disord; 2015; 14():69. PubMed ID: 26380227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.
    Heerspink HJL; Sattar N; Pavo I; Haupt A; Duffin KL; Yang Z; Wiese RJ; Tuttle KR; Cherney DZI
    Lancet Diabetes Endocrinol; 2022 Nov; 10(11):774-785. PubMed ID: 36152639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes.
    Limonte CP; Valo E; Montemayor D; Afshinnia F; Ahluwalia TS; Costacou T; Darshi M; Forsblom C; Hoofnagle AN; Groop PH; Miller RG; Orchard TJ; Pennathur S; Rossing P; Sandholm N; Snell-Bergeon JK; Ye H; Zhang J; Natarajan L; de Boer IH; Sharma K
    Am J Nephrol; 2020; 51(10):839-848. PubMed ID: 33053547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
    Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
    JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study.
    Tan JK; Lim GH; Mohamed Salim NN; Chia SY; Thumboo J; Bee YM
    Clin Epidemiol; 2023; 15():137-149. PubMed ID: 36721457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Wexler DJ; de Boer IH; Ghosh A; Younes N; Bebu I; Inzucchi SE; McGill JB; Mudaliar S; Schade D; Steffes MW; Tamborlane WV; Tan MH; Ismail-Beigi F;
    JAMA Intern Med; 2023 Jul; 183(7):705-714. PubMed ID: 37213109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Blood Pressure Changes and Kidney Function Decline in Persons Without Chronic Kidney Disease: Findings From the MESA Study.
    Judson GL; Rubinsky AD; Shlipak MG; Katz R; Kramer H; Jacobs DR; Odden MC; Peralta CA
    Am J Hypertens; 2018 Apr; 31(5):600-608. PubMed ID: 29036269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
    Heerspink HJL; Karasik A; Thuresson M; Melzer-Cohen C; Chodick G; Khunti K; Wilding JPH; Garcia Rodriguez LA; Cea-Soriano L; Kohsaka S; Nicolucci A; Lucisano G; Lin FJ; Wang CY; Wittbrodt E; Fenici P; Kosiborod M
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):27-35. PubMed ID: 31862149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.